Ilex Medical Management
Management criteria checks 4/4
We currently do not have sufficient information about the CEO.
Key information
Boaz Yehazkel
Chief executive officer
₪2.0m
Total compensation
| CEO salary percentage | 73.15% |
| CEO tenure | no data |
| CEO ownership | n/a |
| Management average tenure | 3.3yrs |
| Board average tenure | 3.4yrs |
Recent management updates
We Think Ilex Medical Ltd's (TLV:ILX) CEO Compensation Package Needs To Be Put Under A Microscope
Sep 24
What Can We Make Of Ilex Medical's (TLV:ILX) CEO Compensation?
Nov 28
Recent updates
Ilex Medical Ltd's (TLV:ILX) 26% Share Price Surge Not Quite Adding Up
Dec 06We Think Ilex Medical Ltd's (TLV:ILX) CEO Compensation Package Needs To Be Put Under A Microscope
Sep 24Earnings Troubles May Signal Larger Issues for Ilex Medical (TLV:ILX) Shareholders
Sep 04Ilex Medical Ltd (TLV:ILX) Investors Are Less Pessimistic Than Expected
Jan 02Ilex Medical (TLV:ILX) Could Easily Take On More Debt
Feb 13The Trend Of High Returns At Ilex Medical (TLV:ILX) Has Us Very Interested
Nov 25Returns On Capital Are A Standout For Ilex Medical (TLV:ILX)
Jun 03Here's Why We Think Ilex Medical (TLV:ILX) Is Well Worth Watching
May 04Ilex Medical (TLV:ILX) Could Easily Take On More Debt
Apr 02Is It Smart To Buy Ilex Medical Ltd (TLV:ILX) Before It Goes Ex-Dividend?
Mar 20Ilex Medical (TLV:ILX): Are Investors Overlooking Returns On Capital?
Mar 02Are Robust Financials Driving The Recent Rally In Ilex Medical Ltd's (TLV:ILX) Stock?
Feb 16What Type Of Shareholders Make Up Ilex Medical Ltd's (TLV:ILX) Share Registry?
Feb 04Here's Why I Think Ilex Medical (TLV:ILX) Is An Interesting Stock
Jan 24Shareholders of Ilex Medical (TLV:ILX) Must Be Delighted With Their 333% Total Return
Jan 11Ilex Medical (TLV:ILX) Has A Rock Solid Balance Sheet
Dec 23What Can We Make Of Ilex Medical's (TLV:ILX) CEO Compensation?
Nov 28CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2024 | n/a | n/a | ₪46m |
| Sep 30 2024 | n/a | n/a | ₪55m |
| Jun 30 2024 | n/a | n/a | ₪51m |
| Mar 31 2024 | n/a | n/a | ₪56m |
| Dec 31 2023 | ₪2m | ₪1m | ₪56m |
| Sep 30 2023 | n/a | n/a | ₪67m |
| Jun 30 2023 | n/a | n/a | ₪77m |
| Mar 31 2023 | n/a | n/a | ₪66m |
| Dec 31 2022 | ₪2m | ₪1m | ₪108m |
| Sep 30 2022 | n/a | n/a | ₪107m |
| Jun 30 2022 | n/a | n/a | ₪172m |
| Mar 31 2022 | n/a | n/a | ₪203m |
| Dec 31 2021 | ₪2m | ₪1m | ₪197m |
| Sep 30 2021 | n/a | n/a | ₪185m |
| Jun 30 2021 | n/a | n/a | ₪150m |
| Mar 31 2021 | n/a | n/a | ₪146m |
| Dec 31 2020 | ₪2m | ₪1m | ₪121m |
| Sep 30 2020 | n/a | n/a | ₪101m |
| Jun 30 2020 | n/a | n/a | ₪71m |
| Mar 31 2020 | n/a | n/a | ₪61m |
| Dec 31 2019 | ₪2m | ₪1m | ₪60m |
Compensation vs Market: Boaz's total compensation ($USD569.64K) is about average for companies of similar size in the IL market ($USD619.79K).
Compensation vs Earnings: Boaz's compensation has been consistent with company performance over the past year.
CEO
Boaz Yehazkel (64 yo)
Mr. Boaz Yehazkel is Chief Executive Officer of Ilex Medical Ltd. Mr. Yehazkel was Chief Executive Officer of Medtechnica Ltd of Ilex Medical Ltd from 2015.
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder & Chairman | 9.3yrs | ₪2.33m | 58.41% ₪ 423.2m | |
| Chief Executive Officer | no data | ₪2.01m | no data | |
| Deputy Chief Executive Officer of Sales & Business Development | 5.4yrs | ₪1.48m | no data | |
| Vice President of Customer Experience | 6.3yrs | ₪1.33m | no data | |
| Chief Financial Officer | 3.3yrs | no data | no data | |
| Vice President of Operations & Technologies | no data | ₪1.10m | 1.45% ₪ 10.5m | |
| Accountant | 2.3yrs | no data | no data | |
| General Counsel & Company Secretary | 3.3yrs | no data | no data | |
| Vice President of Marketing & Sales-Department Microbiology | 1.3yrs | no data | no data |
Experienced Management: ILX's management team is considered experienced (3.3 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder & Chairman | 9.3yrs | ₪2.33m | 58.41% ₪ 423.2m | |
| Independent Director | 3.3yrs | no data | no data | |
| Director | 3.4yrs | no data | no data | |
| Independent Director | 3.4yrs | no data | no data | |
| Independent Director | 4.2yrs | no data | no data |
Experienced Board: ILX's board of directors are considered experienced (3.4 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/05/19 12:52 |
| End of Day Share Price | 2025/05/19 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Ilex Medical Ltd is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.